logo
Plus   Neg
Share
Email

Novo Nordisk Announces Approval Of Rybelsus In Japan For Treatment Of Type 2 Diabetes

Novo Nordisk (NVO) announced the Japanese Ministry of Health, Labour and Welfare has approved Rybelsus for the treatment of adults with type 2 diabetes. It is administered orally once daily and is approved for use in three therapeutic dosages, 3 mg, 7 mg and 14 mg in Japan. The approval is based on the PIONEER programme.

Novo Nordisk said the company will now initiate reimbursement negotiations and expects to launch Rybelsus in Japan thereafter. Novo Nordisk and MSD will be co-promoting Rybelsus in Japan.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A new class-action lawsuit filed against Facebook accuses the company's photo and video-sharing app Instagram of illegally collecting biometric data of as many as 100 million users without their consent, according to reports. The lawsuit filed in a state court in California, alleges that Instagram uses its photo-tagging technology to create a database of users' facial features. Stein Mart, Inc. has joined the ever growing list of U.S. retailers who filed for bankruptcy protection amid the ongoing coronavirus (COVID-19) pandemic. The beleaguered off-price retailer filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Middle District of Florida. United Airlines said it is adding up to 28 daily nonstop flights this winter to Florida, in its efforts to manage the impact of COVID-19. The airline is increasing services to 'destinations where customers most want to fly'. The new round trip services will connect customers in Boston, Cleveland, Indianapolis, Milwaukee, New York/LaGuardia, Pittsburgh and Columbus, Ohio to four popular Florida...
Follow RTT